ELMMB logo
Facebook logo Twitter logo
Menu
MHRA Drug Safety Updates

MHRA Drug Safety Updates

MHRA Yellow Card Scheme: please help to reverse the decline in reporting of suspected adverse drug reactions 

Drug Safety Update MHRA November 2019-PDF.pdf

Drug Safety Update MHRA November 2019-PDF.pdf
Summary: Yellow fever vaccine: Carfilzomib (Kyprolisâ–¼): risk of reactivation of hepatitis B virus:
File Size: 252KB
File Type: application/pdf
Created: 22 November 2019
Last Modified: 09 April 2020